The first instalment includes Dr Schmidt’s and Dr Zbar’s talks. 

Dr Laura Schmidt: Introduction to the Second BHD Symposium 2010

Dr Laura Schmidt is currently a staff scientist at the Center for Cancer Research, National Cancer Institute, NIH, USA. Dr Schmidt’s research focuses on identifying new genes involved in familial renal cancer. Dr Schmidt was part of the team that cloned the VHL tumor suppressor gene, and that identified mutations in folliculin, the gene mutated in BHD syndrome.

Dr Berton Zbar: A personal view of renal cancer genetics: history and lessons

This year’s invited guest speaker was Dr. Berton Zbar, who has over 20 years experience in the field of renal cancer genetics.

Before his retirement, Dr Zbar was chief of the Laboratory of Immunobiology at the Center for Cancer Research, National Cancer Institute, NIH, USA, where he and his colleagues  studied families affected with the BHD Syndrome as well as von Hippel-Lindau (VHL) syndrome, hereditary papillary renal carcinoma (HPRC), and Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC).